Welcome to our dedicated page for Eltek SEC filings (Ticker: ELTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Eltek Ltd (NASDAQ: ELTK) files annual and interim reports with the U.S. Securities and Exchange Commission as a foreign private issuer under Form 20-F and Form 6-K. This SEC filings page aggregates those documents so investors can follow the company’s official financial and corporate disclosures alongside AI-generated summaries.
Eltek’s Form 20-F annual report includes audited consolidated financial statements, detailed notes, and discussions of its business as a global manufacturer and supplier of technologically advanced printed circuit boards (PCBs). The company also files multiple Form 6-K reports during the year, which, as disclosed in recent filings, furnish press releases on quarterly financial results, interim condensed consolidated financial statements, management’s discussion and analysis, notices and results of shareholder meetings, purchase order announcements and dividend declarations.
Through these filings, readers can track Eltek’s revenues, profitability, cash flows, investment program for new equipment and production lines, and information about its role as an Israeli leading company in the high-end PCB industry. The filings also describe its customer base in defense, aerospace and medical markets, its global footprint, and its use of non-GAAP measures such as EBITDA.
Stock Titan’s tools present Eltek’s SEC filings with AI-powered highlights that help explain the structure and key points of lengthy documents, such as annual reports and interim financial statements. Users can quickly identify major trends, important risk disclosures and significant corporate actions without reading every line. Real-time updates from EDGAR ensure that new Form 6-K and Form 20-F submissions, as well as other relevant filings, appear promptly, giving ELTK investors a structured view of the company’s regulatory record.
Eltek Ltd. reported new purchase orders totaling approximately $5.3 million from an international customer. Deliveries are scheduled to begin in the second quarter of 2026, with final shipments expected by September 2027.
The company also indicated that operating results for the first quarter of 2026 will be adversely affected by a less favorable fulfillment mix in its order backlog and unexpected logistics issues, even though its backlog has approximately doubled compared to year-end 2025. Eltek expects deliveries to gradually normalize over time.
ELTEK LTD reported that Chief Information Officer Yaniv Luria holds employee stock options over 10,000 ordinary shares with an exercise price of $9.78 expiring on August 14, 2034, and options over 15,000 ordinary shares at $8.82 expiring on March 8, 2036. Both option grants vest over four years, with 25% vesting after one year from the grant date and 6.25% at the end of each following quarter.
Eltek Ltd., a global manufacturer of advanced printed circuit boards, filed its 2025 annual report with the U.S. Securities and Exchange Commission. The filing includes audited consolidated financial statements for the year ended December 31, 2025.
The annual report is available on Eltek’s website, and shareholders can request a hard copy free of charge. Eltek highlights its focus on complex, high-quality PCB solutions for defense, aerospace, medical and other high-end markets across Israel, the United States, Europe and Asia.
Eltek Ltd., an Israel-based manufacturer of advanced custom printed circuit boards, reports on its 2025 fiscal year and outlines extensive risk factors. The company had 6,719,827 ordinary shares outstanding as of December 31, 2025 and prepares U.S. GAAP financials in U.S. dollars.
Eltek serves defense and aerospace, medical, industrial, telecom and networking customers with HDI, flex-rigid and high-layer-count rigid PCBs. Key themes include dependence on aging, unique machinery, concentration of revenues among a few large customers and suppliers, exposure to volatile raw-material markets, and sensitivity to NIS/U.S. dollar exchange rates.
The report highlights environmental compliance and penalties in Israel, potential additional remediation costs, cyber and IT risks, possible capital needs despite $12.1 million in cash and $25.0 million in working capital, as well as geopolitical and security risks arising from conflicts involving Israel, Hamas and Iran.
Eltek Ltd director Erez Meltzer has filed an initial ownership report showing holdings of employee stock options tied to Eltek ordinary shares. One option grants rights over 20,000 ordinary shares at an exercise price of $5.8900 per share, expiring on September 6, 2031. A second option covers 10,000 ordinary shares at an exercise price of $8.6700 per share, expiring on October 6, 2033. Each option vests over four years, with 25% becoming exercisable on the first anniversary of its grant date and 6.25% additional vesting at the end of each subsequent quarter.
Eltek Ltd director Cohen Tsemah Revital filed an initial ownership report showing existing employee stock options, not new share purchases or sales. The holdings include options over 3,750 ordinary shares at an exercise price of $4.94, expiring on March 24, 2031, and options over 8,000 ordinary shares at $8.70, expiring on August 3, 2033. Both option grants vest over four years, with 25% vesting on the first anniversary of the grant date and 6.25% vesting at the end of each following quarter.
ELTEK LTD Chief Financial Officer Ron Freund filed an initial ownership report showing both ordinary shares and multiple employee stock option grants. He directly holds 7,558 ordinary shares, plus options over 58,500 ordinary shares at exercise prices ranging from $3.60 to $15.83 per share with expirations between 2031 and 2036. Footnotes state that each option grant vests over four years, with 25% vesting after one year and 6.25% vesting at the end of each subsequent quarter.
Eltek Ltd director Mordechai Marmorstein has reported existing employee stock option holdings in a Form 3 filing. He holds options over 10,000 ordinary shares at an exercise price of $5.8900 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.6700 per share expiring on October 6, 2033. Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and 6.25% at the end of each following quarter. The earlier grant was made on September 6, 2021, and the later grant on October 10, 2023.
ELTEK LTD executive Yitzhak Zemach, Vice President Operations, has reported his existing equity holdings on a Form 3. The filing lists five grants of employee stock options over a total of 42,500 underlying ordinary shares, with exercise prices ranging from $4.9400 to $15.8300 and expirations between 2031 and 2036. Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and an additional 6.25% at the end of each following quarter.
ELTEK LTD director Ilana Lurie reported existing equity awards in the form of employee stock options. She holds options over 10,000 ordinary shares at an exercise price of $5.8900 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.6700 per share expiring on October 6, 2033.
Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant dates in September 2021 and October 2023, and an additional 6.25% becoming exercisable at the end of each subsequent quarter.